Genital herpes

New England Journal of Medicine

Volumn 375, Issue 7, 2016, Pages 666-674

  Gnann, John W ^a   Whitley, Richard J ^b  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^b University of Alabama at Birmingham   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACICLOVIR; FAMCICLOVIR; IMMUNOGLOBULIN G; THROMBOSPONDIN; VALACICLOVIR; ANTIVIRUS AGENT;

ADULT; AMERICAN; ANGER; ARTICLE; CASE REPORT; CONDOM USE; CONTROLLED STUDY; DEPRESSION; DISEASE COURSE; DISEASE TRANSMISSION; DRUG EFFICACY; DYSURIA; ENZYME LINKED IMMUNOSORBENT ASSAY; FEAR; FEAR OF DISCOVERY; FEAR OF REJECTION; FEMALE; FEVER; GENITAL HERPES; HEADACHE; HERPES SIMPLEX VIRUS 1; HERPES SIMPLEX VIRUS 2; HUMAN; INCUBATION TIME; INGUINAL LYMPHADENOPATHY; LYMPHADENOPATHY; MALAISE; MALE; NONHUMAN; PLACENTAL TRANSFER; POLYMERASE CHAIN REACTION; PREVALENCE; PRIORITY JOURNAL; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; RECURRENT DISEASE; RISK REDUCTION; SENSITIVITY AND SPECIFICITY; SEXUAL BEHAVIOR; SHAME; THIRD TRIMESTER PREGNANCY; VIRUS CULTURE; VIRUS REACTIVATION; WESTERN BLOTTING; HERPES GENITALIS; ISOLATION AND PURIFICATION; PRACTICE GUIDELINE; PREVENTION AND CONTROL; TRANSMISSION;

ADULT; ANTIVIRAL AGENTS; DISEASE TRANSMISSION, INFECTIOUS; FEMALE; HERPES GENITALIS; HERPESVIRUS 1, HUMAN; HERPESVIRUS 2, HUMAN; HUMANS; PRACTICE GUIDELINES AS TOPIC;

EID: 84982107145     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMcp1603178     Document Type: Article

References (50)

1. Bradley H, Markowitz LE, Gibson T, McQuillan GM. Seroprevalence of herpes simplex virus types 1 and 2 - United States, 1999-2010. J Infect Dis 2014; 209: 325-33.
2. Fanfair RN, Zaidi A, Taylor LD, Xu F, Gottlieb S, Markowitz L. Trends in seroprevalence of herpes simplex virus type 2 among non-Hispanic blacks and non-Hispanic whites aged 14 to 49 years - United States, 1988 to 2010. Sex Transm Dis 2013; 40: 860-4.
3. Stanberry LR, Rosenthal SL, Mills L, et al. Longitudinal risk of herpes simplex virus (HSV) type 1, HSV type 2, and cytomegalovirus infections among young adolescent girls. Clin Infect Dis 2004; 39: 1433-8.
4. Okafor N, Rosenberg ES, Luisi N, et al. Disparities in herpes simplex virus type 2 infection between black and white men who have sex with men in Atlanta, GA. Int J STD AIDS 2015; 26: 740-5.
5. Abu-Raddad LJ, Magaret AS, Celum C, et al. Genital herpes has played a more important role than any other sexually transmitted infection in driving HIV prevalence in Africa. Plos One 2008; 3(5): E2230.
6. Xu F, Lee FK, Morrow RA, et al. Seroprevalence of herpes simplex virus type 1 in children in the United States. J Pediatr 2007; 151: 374-7.
7. Ryder N, Jin F, McNulty AM, Grulich AE, Donovan B. Increasing role of herpes simplex virus type 1 in first-episode anogenital herpes in heterosexual women and younger men who have sex with men, 1992-2006. Sex Transm Infect 2009; 85: 416-9.
8. Bernstein DI, Bellamy AR, Hook EW III, et al. Epidemiology, clinical presentation, and antibody response to primary infection with herpes simplex virus type 1 and type 2 in young women. Clin Infect Dis 2013; 56: 344-51.
9. Engelberg R, Carrell D, Krantz E, Corey L, Wald A. Natural history of genital herpes simplex virus type 1 infection. Sex Transm Dis 2003; 30: 174-7.
10. Leone P, Fleming DT, Gilsenan AW, Li L, Justus S. Seroprevalence of herpes simplex virus-2 in suburban primary care offices in the United States. Sex Transm Dis 2004; 31: 311-6.
11. Schulte JM, Bellamy AR, Hook EW III, et al. HSV-1 and HSV-2 seroprevalence in the United States among asymptomatic women unaware of any herpes simplex virus infection (Herpevac Trial for Women). South Med J 2014; 107: 79-84.
12. Tronstein E, Johnston C, Huang ML, et al. Genital shedding of herpes simplex virus among symptomatic and asymptomatic persons with HSV-2 infection. JAMA 2011; 305: 1441-9.
13. Corey L, Wald A, Patel R, et al. Oncedaily valacyclovir to reduce the risk of transmission of genital herpes. N Engl J Med 2004; 350: 11-20.
14. Dhankani V, Kutz JN, Schiffer JT. Herpes simplex virus-2 genital tract shedding is not predictable over months or years in infected persons. Plos Comput Biol 2014; 10(11): E1003922.
15. Schiffer JT, Mayer BT, Fong Y, Swan DA, Wald A. Herpes simplex virus-2 transmission probability estimates based on quantity of viral shedding. J R Soc Interface 2014; 11: 20140160.
16. James SH, Kimberlin DW. Neonatal herpes simplex virus infection: Epidemiology and treatment. Clin Perinatol 2015; 42: 47-59, viii.
17. Brown ZA, Wald A, Morrow RA, Selke S, Zeh J, Corey L. Effect of serologic status and cesarean delivery on transmission rates of herpes simplex virus from mother to infant. JAMA 2003; 289: 203-9.
18. Ashley-Morrow R, Nollkamper J, Robinson NJ, Bishop N, Smith J. Performance of focus ELISA tests for herpes simplex virus type 1 (HSV-1) and HSV-2 antibodies among women in ten diverse geographical locations. Clin Microbiol Infect 2004; 10: 530-6.
19. Mark HD, Nanda JP, Roberts J, Rompalo A, Melendez JH, Zenilman J. Performance of focus ELISA tests for HSV-1 and HSV-2 antibodies among university students with no history of genital herpes. Sex Transm Dis 2007; 34: 681-5.
20. Morrow RA, Friedrich D, Krantz E. Performance of the Focus and Kalon enzyme- linked immunosorbent assays for antibodies to herpes simplex virus type 2 glycoprotein G in culture-documented cases of genital herpes. J Clin Microbiol 2003; 41: 5212-4.
21. Summerton J, Riedesel M, Laeyendecker O, et al. Effect of sexually transmitted disease (STD) coinfections on performance of three commercially available immunosorbent assays used for detection of herpes simplex virus type 2-specific antibody in men attending Baltimore, Maryland, STD clinics. Clin Vaccine Immunol 2007; 14: 1545-9.
22. Workowski KA, Bolan GA. Sexually transmitted diseases treatment guidelines, 2015. MMWR Recomm Rep 2015; 64(RR-03): 1-137.
23. Ramaswamy M, McDonald C, Smith M, et al. Diagnosis of genital herpes by real time PCR in routine clinical practice. Sex Transm Infect 2004; 80: 406-10.
24. Bryson YJ, Dillon M, Lovett M, et al. Treatment of first episodes of genital herpes simplex virus infection with oral acyclovir - A randomized double-blind controlled trial in normal subjects. N Engl J Med 1983; 308: 916-21.
25. Fife KH, Barbarash RA, Rudolph T, Degregorio B, Roth R. Valaciclovir versus acyclovir in the treatment of first-episode genital herpes infection: Results of an international, multicenter, double-blind, randomized clinical trial. Sex Transm Dis 1997; 24: 481-6.
26. Fife KH, Almekinder J, Ofner S. A comparison of one year of episodic or suppressive treatment of recurrent genital herpes with valacyclovir. Sex Transm Dis 2007; 34: 297-301.
27. Reichman RC, Badger GJ, Mertz GJ, et al. Treatment of recurrent genital herpes simplex infections with oral acyclovir: A controlled trial. JAMA 1984; 251: 2103-7.
28. Sacks SL, Aoki FY, Diaz-Mitoma F, Sellors J, Shafran SD. Patient-initiated, twice-daily oral famciclovir for early recurrent genital herpes: A randomized, double-blind multicenter trial. JAMA 1996; 276: 44-9.
29. Tyring SK, Douglas JM Jr, Corey L, Spruance SL, Esmann J. A randomized, placebo-controlled comparison of oral valacyclovir and acyclovir in immunocompetent patients with recurrent genital herpes infections. Arch Dermatol 1998; 134: 185-91.
30. Diaz-Mitoma F, Sibbald RG, Shafran SD, Boon R, Saltzman RL. Oral famciclovir for the suppression of recurrent genital herpes: A randomized controlled trial. JAMA 1998; 280: 887-92.
31. Douglas JM, Critchlow C, Benedetti J, et al. A double-blind study of oral acyclovir for suppression of recurrences of genital herpes simplex virus infection. N Engl J Med 1984; 310: 1551-6.
32. Wald A, Selke S, Warren T, et al. Comparative efficacy of famciclovir and valacyclovir for suppression of recurrent genital herpes and viral shedding. Sex Transm Dis 2006; 33: 529-33.
33. Gupta R, Wald A, Krantz E, et al. Valacyclovir and acyclovir for suppression of shedding of herpes simplex virus in the genital tract. J Infect Dis 2004; 190: 1374- 81.
34. Ross K, Johnston C, Wald A. Herpes simplex virus type 2 serological testing and psychosocial harm: A systematic review. Sex Transm Infect 2011; 87: 594-600.
35. Wald A, Krantz E, Selke S, Lairson E, Morrow RA, Zeh J. Knowledge of partners' genital herpes protects against herpes simplex virus type 2 acquisition. J Infect Dis 2006; 194: 42-52.
36. Wald A, Langenberg AG, Krantz E, et al. The relationship between condom use and herpes simplex virus acquisition. Ann Intern Med 2005; 143: 707-13.
37. Martin ET, Krantz E, Gottlieb SL, et al. A pooled analysis of the effect of condoms in preventing HSV-2 acquisition. Arch Intern Med 2009; 169: 1233-40.
38. Magaret AS, Mujugira A, Hughes JP, et al. Effect of condom use on per- Act HSV-2 transmission risk in HIV-1, HSV-2-discordant couples. Clin Infect Dis 2016; 62: 456-61.
39. Delaney S, Gardella C, Daruthayan C, et al. A prospective cohort study of partner testing for herpes simplex virus and sexual behavior during pregnancy. J Infect Dis 2012; 206: 486-94.
40. ACOG Committee on Practice Bulletins. ACOG practice bulletin: clinical management guidelines for obstetriciangynecologists. No. 82, June 2007. Management of herpes in pregnancy. Obstet Gynecol 2007; 109: 1489-98.
41. Stone KM, Reiff-Eldridge R, White AD, et al. Pregnancy outcomes following systemic prenatal acyclovir exposure: conclusions from the international Acyclovir Pregnancy Registry, 1984-1999. Birth Defects Res A Clin Mol Teratol 2004; 70: 201-7.
42. Sheffield JS, Hill JB, Hollier LM, et al. Valacyclovir prophylaxis to prevent recurrent herpes at delivery: A randomized clinical trial. Obstet Gynecol 2006; 108: 141-7.
43. Belshe RB, Leone PA, Bernstein DI, et al. Efficacy results of a trial of a herpes simplex vaccine. N Engl J Med 2012; 366: 34-43.
44. Johnston C, Koelle DM, Wald A. Current status and prospects for development of an HSV vaccine. Vaccine 2014; 32: 1553- 60.
45. Geretti AM. Genital herpes. Sex Transm Infect 2006; 82: Suppl4: iv31-4.
46. Mark HD. Asymptomatic sexually active adolescents and young adults should not be screened for herpes simplex virus. JAMA Pediatr 2013; 167: 691-2.
47. Wald A. Knowledge is power: A case for wider herpes simplex virus serologic testing. JAMA Pediatr 2013; 167: 689-90.
48. Patel R, Alderson S, Geretti A, et al. European guideline for the management of genital herpes, 2010. Int J STD AIDS 2011; 22: 1-10.
49. Money D, Steben M. SOGC clinical practice guidelines: guidelines for the management of herpes simplex virus in pregnancy. Number 208, June 2008. Int J Gynaecol Obstet 2009; 104: 167-71.
50. Money D, Steben M. SOGC clinical practice guidelines: genital herpes: gynaecological aspects. Number 207, April 2008. Int J Gynaecol Obstet 2009; 104: 162-6.